scholarly journals The Reliability and Validity of the Hebrew Patient Health Questionnaire (PHQ-9) in the General Population

Author(s):  
Tomer Yona ◽  
Asaf Weisman ◽  
Uri Gottlieb ◽  
Eshed Lin ◽  
Youssef Masharawi

Objective: To assess the psychometric properties of the Hebrew version of the Patient Health Questionnaire (PHQ-9) in the general population. Methods: Using an online survey, we assessed test-retest reliability with a two-week time interval. A total of 118 participants enrolled in the study, of whom 103 completed the survey twice. Each participant filled out the PHQ-9 and the 12-Item Short Form Survey (SF-12). Our statistical analysis includes Cronbachs alpha, Intraclass Correlation Coefficient (ICC2,1), Spearmans rank correlation coefficient, Standard Error of Measurement (SEM), and Minimal Detectable Change (MDC). Results: Internal consistency of the Hebrew version of the PHQ-9 ranged from alpha=0.79-0.83. The test-retest reliability of the questionnaire is good (ICC2,1= 0.81), and it is moderately and negatively correlated to the mental component of the SF-12 (Spearman rho;= -0.57, p< .05). The SEM of the PHQ-9 is 1.83 points, and the MDC was found to be 5 points. Conclusion: The Hebrew version of the PHQ-9 is valid and reliable for screening self-reported depressive symptoms online in the general Hebrew-speaking population.

2018 ◽  
Author(s):  
Sarah Patrick ◽  
Peter Connick

AbstractBackgroundDepression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to a lack of uptake for brief assessment tools and uncertainty about their psychometric properties. The 9-item Patient Health Questionnaire (PHQ-9) is an attractive candidate for this role.ObjectiveTo synthesise published findings on the psychometric properties of the 9-item Patient Health Questionnaire (PHQ-9) when applied to people with multiple sclerosis (pwMS).Data sourcesPubMed, Medline and ISI Web of Science databases, supplemented by hand-searching of references from all eligible sources.Study eligibility criteriaPrimary literature written in English and published following peer-review with a primary aim to evaluate the performance of the PHQ-9 in pwMS.Outcome measuresPsychometric performance with respect to appropriateness, reliability, validity, responsiveness, precision, interpretability, acceptability, and feasibility.ResultsSeven relevant studies were identified, these were of high quality and included 5080 participants from all MS disease-course groups. Strong evidence was found supporting the validity of the PHQ-9 as a unidimensional measure of depression. Used as a screening tool for major depressive disorder (MDD) with a cut-point of 11, sensitivity was 95% sensitivity and specificity 88.3% (PPV 51.4%, NPV 48.6%). Alternative scoring systems that may address the issue of overlap between somatic features of depression and features of MS per se are being developed, although their utility remains unclear. However data on reliability was limited, and no specific evidence was available on test-retest reliability, responsiveness, acceptability, or feasibility.ConclusionsThe PHQ-9 represents a suitable tool to screen for MDD in pwMS. However use as a diagnostic tool cannot currently be recommended, and the potential value for monitoring depressive symptoms cannot be established without further evidence on test-retest reliability, responsiveness, acceptability, and feasibility.PROSPERO register ID: CRD42017067814


10.2196/17320 ◽  
2020 ◽  
Vol 8 (5) ◽  
pp. e17320
Author(s):  
Miyeon Jung ◽  
SaeByul Lee ◽  
Jisun Kim ◽  
HeeJeong Kim ◽  
BeomSeok Ko ◽  
...  

Background Electronic patient-reported outcome (PROs) provides a fast and reliable assessment of a patient’s health-related quality of life. Nevertheless, using PRO in the traditional paper format is not practical for clinical practice due to the limitations associated with data analysis and management. A questionnaire app was developed to address the need for a practical way to group and use distress and physical activity assessment tools. Objective The purpose of this study was to assess the level of agreement between electronic (mobile) and paper-and-pencil questionnaire responses. Methods We validated the app version of the distress thermometer (DT), International Physical Activity Questionnaire (IPAQ), and Patient Health Questionnaire–9 (PHQ-9). A total of 102 participants answered the paper and app versions of the DT and IPAQ, and 96 people completed the PHQ-9. The study outcomes were the correlation of the data between the paper-and-pencil and app versions. Results A total of 106 consecutive breast cancer patients were enrolled and analyzed for validation of paper and electronic (app) versions. The Spearman correlation values of paper and app surveys for patients who responded to the DT questionnaire within 7 days, within 3 days, and on the same day were .415 (P<.001), .437 (P<.001), and .603 (P<.001), respectively. Similarly, the paper and app survey correlation values of the IPAQ total physical activity metabolic equivalent of task (MET; Q2-6) were .291 (P=.003), .324 (P=.005), and .427 (P=.01), respectively. The correlation of the sum of the Patient Health Questionnaire–9 (Q1-9) according to the time interval between the paper-based questionnaire and the app-based questionnaire was .469 for 14 days (P<.001), .574 for 7 days (P<.001), .593 for 3 days (P<.001), and .512 for the same day (P=.03). These were all statistically significant. Similarly, the correlation of the PHQ (Q10) value according to the time interval between the paper-based questionnaire and the app-based questionnaire was .283 for 14 days (P=.005), .409 for 7 days (P=.001), .415 for 3 days (P=.009), and .736 for the same day (P=.001). These were all statistically significant. In the overall trend, the shorter the interval between the paper-and-pencil questionnaire and the app-based questionnaire, the higher the correlation value. Conclusions The app version of the distress and physical activity questionnaires has shown validity and a high level of association with the paper-based DT, IPAQ (Q2-6), and PHQ-9. The app-based questionnaires were not inferior to their respective paper versions and confirm the feasibility for their use in clinical practice. The high correlation between paper and mobile app data allows the use of new mobile apps to benefit the overall health care system. Trial Registration ClinicalTrials.gov NCT03072966; https://clinicaltrials.gov/ct2/show/NCT03072966


2017 ◽  
Vol 41 (S1) ◽  
pp. S523-S523
Author(s):  
H. Belhadj ◽  
R. Jomli ◽  
U. Ouali ◽  
Y. Zgueb ◽  
F. Nacef

IntroductionThe PHQ-9 has been recommended as the best available screening and case-finding instrument for primary care based on its brevity, and ability to inform the clinicians on both depression severity and diagnostic criteria.ObjectiveOur study evaluated the reliability and the validity of the Tunisian version of the PHQ-9 in detecting major depression in general population.MethodWe undertook a cross-sectional and analytical study. A total of 134 participants, representative of the Tunisian general population, were enrolled. The PHQ-9 was validated against the HAD reference standard. The types of validity determined for the PHQ-9 in this study were: translation validity, internal reliability and criterion validity.ResultsTest-Retest reliability was determined by intraclass correlation. This scale is stable over 2 weeks (ICC = 0.97). The Tunisian version of the PHQ-9 was found to have good internal reliability (Cronbach's alpha = 0.84). As for criterion validity of the PHQ-9, the Pearson's correlation coefficient between the PHQ-9 and HAD was 0.94 and the Spearman's correlation coefficient was 0.81. This indicated a positive association of good strength between the two instruments. A cut-off score of 10 or higher on the PHQ-9 had a sensitivity of 86.2 and a specificity of 83.8. The VPP was 0.6 and the VPN was 0.9.ConclusionThe Tunisan version of the PHQ-9 has several potential advantages. It was found to be a valid and reliable casefinding instrument for detecting depression in general population.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2021 ◽  
Vol 73 (4) ◽  
pp. 268-274
Author(s):  
Kingkaew Pajareya ◽  
Chayaporn Chotiyarnwong ◽  
Thapanee Sithawatdecha ◽  
Rattanaporn Wattanasri

Objective: The study objective is to adapt the Lymphoedema functioning, disability and health questionnaire (Lymph-ICF) for use in the Thai language and to investigate the validity and reliability of the Thai version.Materials and Methods: This study was done in 5 stages in line with established guidelines for cross-cultural adaptation of self-report measures; 1) Initial translation 2) Synthesis of the translations 3) Back translation 4) Expert committee review and 5) Test of the prefinal version. The face validity was assessed by interview content experts. In the assessment of the validity of the construct, the Spearman correlation coefficient was used to examine the correlations between the scores of the Thai Lymph-ICF and the scores of the Thai EQ-5D-5L. The intraclass correlation coefficient (ICC) was used to establish test-retest reliability while Cronbach’s alpha was used to determine the internal consistency of the whole questionnaire and of each domain.Results: Fifty participants were evaluated for validity and reliability. Face validity was supported. Construct validity showed strong correlations between the scores of the Thai Lymph-ICF and the scores of the Thai EQ-5D-5L. Internal consistency and test-retest reliability were both excellent.Conclusion: The Lymph-ICF Thai version was shown to be both valid and reliable for evaluating the quality of life of patients with breast cancer-related lymphoedema.


Sign in / Sign up

Export Citation Format

Share Document